Cannara Biotech Inc. (LOVFF)
OTCMKTS · Delayed Price · Currency is USD
1.220
+0.020 (1.67%)
At close: Nov 3, 2025
Cannara Biotech Market Cap
Cannara Biotech has a market cap or net worth of $109.73 million as of November 4, 2025. Its market cap has increased by 162.29% in one year.
Market Cap
109.73M
Enterprise Value
133.21M
Revenue
74.05M
Ranking
n/a
PE Ratio
9.73
Stock Price
$1.22
Market Cap Chart
Since January 14, 2019, Cannara Biotech's market cap has decreased from 159.42M to 109.73M, a decrease of -31.17%. That is a compound annual growth rate of -5.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 3, 2025 | 109.90M | 137.39% |
| Dec 31, 2024 | 46.30M | -18.17% |
| Dec 29, 2023 | 56.58M | -8.15% |
| Dec 30, 2022 | 61.59M | -34.13% |
| Dec 31, 2021 | 93.50M | 101.84% |
| Dec 31, 2020 | 46.32M | -31.99% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jan 14, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 815.18M |
| Elite Pharmaceuticals | 666.34M |
| Glass House Brands | 577.78M |
| Northwest Biotherapeutics | 390.01M |
| Silence Therapeutics | 312.22M |
| Nika Pharmaceuticals | 311.89M |
| American Oncology Network | 305.39M |
| CytoDyn | 297.30M |